Chronic kidney disease (CKD) has been increasingly recognised as a public health issue. The estimated worldwide prevalence of CKD is 8%-16% [1]. CKD was the 16th leading cause of death in 2016 and is expected to be the fifth leading cause by 2040 [2]. In Vietnam, the prevalence of CKD and end-stage renal disease (ESRD) has been continuously increasing, reaching nearly 90,000 patients with ESRD annually. Up to 9000 incident cases are underdiagnosed and undertreated every year. By the end of 2016, only approximately 21,000 patients underwent haemodialysis (HD), peritoneal dialysis (PD) or renal transplantation [3]. Patients with ESRD not only experience a decrease in life expectancy but also bear the burden of illness with various comorbidities. Moreover, prolonged treatment duration could consume substantial healthcare resources for management and further deteriorate the patient's quality of life (QoL) and survival rates [4,5].